Leading Cardiology Practice Joins MedeFile's Quality of Care Program

Dec 08, 2010, 08:54 ET from MedeFile International, Inc.

BOCA RATON, Fla., Dec. 8, 2010 /PRNewswire/ -- MedeFile International, Inc. (OTC Bulletin Board: MDFI), a leader in portable electronic medical records management, announced today the addition of Bartzokis, Rubenstein and Servoss cardiology practice, as well as noted gastroenterologist, Dr. David Hellman, to its innovative Quality of Care program.

MedeFile's Quality of Care program partners with doctors, medical practices, and private hospitals, to educate their patients about the importance of MedeFile's Personal Health Record.

Bartzokis, Rubenstein & Servoss, M.D., P.L. is an experienced specialty group that has grown to become one of the region's leaders in diagnosis, treatment, and prevention of cardiovascular diseases, providing unparalleled cardiovascular care to the South Florida community since 1991. With four full-time cardiologists, BR&S provides full consultative cardiac services as well as expertise in coronary, peripheral, and carotid intervention.

Dr. David Hellman's thriving Boynton Beach, FL gastroenterology practice is growing at an exponential rate and Dr. Hellman is fast becoming the most highly regarded gastroenterologist in the region.

Dr. Hellman said, "MedeFile, literally, makes my job easier.  With MedeFile, my patients will have their entire medical history available to me in an organized, comprehensive manner.  I always advise my patients to provide me with as much information on their medical history as possible, and I urge each one of them to become a MedeFile member."

"When it comes to cardiology every minute counts, so immediate access to a patient's history is especially crucial.  MedeFile finally makes that a reality," said Dr. Mark Rubenstein of BR&S. "We are genuinely thrilled to be involved in educating and recommending to patients the necessity of MedeFile's Personal Health Records system in maintaining cardiovascular and overall health."

"Kevin Hauser, CEO of MedeFile said, "Adding medical practices to our Quality of Care program is one of our top priorities.  People trust their doctors, and having specialty practices such as BR&S cardiology and Dr. Hellman on board increases potential new customers for MedeFile and emphasizes the importance our Quality of Care program."

About MedeFile International, Inc.

Headquartered in South Florida, MedeFile has a proprietary system for gathering and digitizing medical records so that individuals can have a comprehensive record of all of their medical visits.  MedeFile's primary product is the MedeFile system, a highly secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of its members' actual medical records and create a single, comprehensive medical record that is accessible 24 hours a day, seven days a week. For more information about MedeFile and its annual subscription-based programs, please visit www.medefile.com.

Safe Harbor Statement Under the Private Securities Litigation Act of 1995

With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of MedeFile could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the Company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates, and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, and such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors associated with our Company, review our SEC filings.

Contact:

Investors

1-888-241-0800

investor@medefile.com

SOURCE MedeFile International, Inc.



RELATED LINKS

http://www.medefile.com